市場調查報告書
商品編碼
1533128
歐洲植髮市場預測至 2030 年 - 區域分析 - 按移植程序和部位Europe Hair Transplant Market Forecast to 2030 - Regional Analysis - by Procedure and Site of Transplantation |
2022年歐洲植髮市場價值為20.0458億美元,預計到2030年將達到90.8933億美元;預計 2022 年至 2030 年複合年成長率為 20.8%。
脫髮發生率的增加推動了歐洲毛髮移植市場
導致脫髮的原因有很多,例如休止期脫髮 (TE)、藥物副作用、頭癬和斑禿。 TE是一種常見的脫髮類型,由嚴重感染和長期疾病引起。例如,根據《醫學與生命雜誌》上發表的一篇文章,休止期脫髮是 COVID-19 大流行的影響之一。 COVID-19 帶來的藥物和壓力環境導致了 TE。
增加鋰、BETA-受體阻斷劑、華法林、肝素、安非他明和左旋多巴(Atamet、Larodopa、Sinemet)等藥物的使用也會導致掉髮。此外,許多癌症化療藥物,包括阿黴素,經常導致快速脫髮。此外,頭皮真菌感染是兒童脫髮的主要原因之一。根據 2023 年 PLOS ONE 發表的一篇文章,每年頭癬佔所有感染的 25% 至 30%。斑禿 (AA) 是一種導致脫髮的自體免疫疾病。根據《德國皮膚病學會雜誌》上發表的文章,40% 的患者在 20 歲時首次出現 AA 症狀,83-88% 的患者在 40 歲時首次出現 AA 症狀。各種因素正在推動市場成長。
歐洲植髮市場概況
歐洲植髮市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。該地區在植髮市場中佔有重要佔有率,預計 2022 年至 2030 年複合年成長率將達到顯著水準。歐洲市場的成長歸因於捷克共和國、西班牙、德國、法國和英國等國家禿髮發病率的增加。根據名為“跨種族脫髮”的BLOG,西班牙約 43.6% 的男性人口禿頂或正在經歷脫髮,其次是捷克共和國,約 43% 的男性人口禿頂或禿頂。根據同一來源,德國和法國分別有約 41% 和約 39% 的男性人口禿頭或禿頭。根據 Euromonitor International 的美容調查,2021 年約有 17% 的歐洲人口出現永久性脫髮或禿頭。
歐洲植髮市場收入及 2030 年預測(百萬美元)
歐洲毛髮移植市場細分
歐洲毛髮移植市場根據手術、移植部位和國家進行細分。根據手術方式,歐洲植髮市場分為手術植髮手術和非手術手術。到 2022 年,非手術手術細分市場將佔據更大的市場佔有率。非手術程序細分為富血小板血漿非手術程序、雷射帽等。
從移植部位來看,歐洲植髮市場分為頭皮移植、睫毛移植、眉毛移植、鬍鬚移植、胸部移植等。 2022 年,頭皮移植領域佔據最大的市場佔有率。
根據國家/地區,歐洲植髮市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022年,德國在歐洲毛髮移植市場佔有率中佔據主導地位。
DHI Global Europe Ltd.、Qunomedical GmbH.、The Follicle Clinic 和 HairMax Inc 是歐洲植髮市場的一些領先公司。
The Europe hair transplant market was valued at US$ 2,004.58 million in 2022 and is expected to reach US$ 9,089.33 million by 2030; it is estimated to RECORD a CAGR of 20.8% from 2022 to 2030.
Increasing Incidences of Hair Loss Fuel Europe Hair Transplant Market
Several reasons, such as Telogen Effluvium (TE), drug side effects, tinea capitis, and alopecia areata, are responsible for hair loss. TE is a common type of hair loss caused due to severe infection and prolonged illness. For instance, according to an article published in the Journal of Medicine and Life, telogen effluvium is one of the effects of the COVID-19 pandemic. Medications and stressful circumstances brought on by COVID-19 have resulted in causing TE.
Increasing use of medications such as lithium, beta-blockers, warfarin, heparin, amphetamines, and levodopa (Atamet, Larodopa, Sinemet) can also result in hair loss. In addition, many cancer chemotherapy drugs, including doxorubicin, frequently result in rapid hair loss. Furthermore, fungal infection of the scalp is one of the major reasons for hair loss in children. According to an article published in PLOS ONE in 2023, yearly tinea capitis accounts for 25 to 30% of all infections. Alopecia areata (AA) is an autoimmune disease that causes hair loss. As per the article published in the Journal of the German Society of Dermatology, 40% of patients experience their first AA symptom by age 20, and 83-88% experience it for the first time by age 40. Thus, increasing incidences of hair loss due to various factors are boosting the market growth.
Europe Hair Transplant Market Overview
The Europe hair transplant market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. This region holds a significant share of the hair transplant market and is expected to register a notable CAGR during 2022-2030. The market growth in Europe is attributed to the increasing incidence of baldness in countries such as the Czech Republic, Spain, Germany, France, and the UK. According to a blog named "Hair Loss across Ethnicities", ~43.6% of the male population is bald or experiencing hair loss in Spain, followed by the population in the Czech Republic where ~43% of the male population is bald or balding. According to the same source, ~41% and ~39% of the male population in Germany and France, respectively, is bald or balding. According to Euromonitor International's Beauty Survey, ~17% of the population in Europe reported permanent hair loss or balding in 2021.
Europe Hair Transplant Market Revenue and Forecast to 2030 (US$ Million)
Europe Hair Transplant Market Segmentation
The Europe hair transplant market is segmented based on procedures, site of transplantation, and country. Based on procedures, the Europe hair transplant market is bifurcated into surgical hair transplant procedures and non-surgical procedures. The non-surgical procedures segment held a larger market share in 2022. The surgical hair transplant procedures segment is sub segmented into Follicular Unite Strip Surgery (FUS), Follicular Unit Extraction (FUE), and other surgical procedures. The non-surgical procedures segment is sub segmented into platelet rich plasma non-surgical procedures, laser cap, and others.
In terms of site of transplantation, the Europe hair transplant market is categorized into scalp transplant, eyelash transplant, eyebrow transplant, beard/ moustache transplant, chest transplant, and others. The scalp transplant segment held the largest market share in 2022.
Based on country, the Europe hair transplant market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hair transplant market share in 2022.
DHI Global Europe Ltd., Qunomedical GmbH., The Follicle Clinic, and HairMax Inc are some of the leading companies operating in the Europe hair transplant market.